Literature DB >> 22704872

Long-chain, n-3 fatty acids and physical activity--independent and interactive associations with cardiac autonomic control.

Matthew P Harbaugh1, Stephen B Manuck, J Richard Jennings, Sarah M Conklin, Jeffrey K Yao, Matthew F Muldoon.   

Abstract

BACKGROUND/
OBJECTIVES: Intake of the marine-based, n-3 fatty acids and engagement in physical activity are inversely related to cardiac morbidity and mortality. Among putative mechanisms, both n-3 fatty acids and physical activity may act through modulation of autonomic control of the cardiovascular system. This investigation examined the independent and interactive associations of n-3 fatty acids (eicosapentaenoic and docosahexanenoic acid; EPA, DHA) and physical activity with heart rate variability (HRV).
METHODS: Subjects were 259 healthy 30-54 year-old adults. Serum phospholipid fatty acid composition was employed as a biomarker of dietary n-3 fatty acid exposure. Physical activity based on the Paffenbarger questionnaire was coded as < or ≥ 2000 kcal/week. Standard time-domain (standard deviation of normal-to-normal intervals and root-mean squared of successive differences; SDNN, RMSSD) and frequency domain (high frequency and low frequency power) measures of HRV were derived from resting electrocardiographic recordings.
RESULTS: In linear regression models with covariate adjustment for age, gender and race, greater n-3 fatty acid exposure was associated with greater SDNN and RMSSD, and high physical activity was associated with greater RMSSD. n-3 fatty acid exposure also predicted variation in SDNN, RMSSD, and high-frequency power in interaction with physical activity. Specifically, n-3 fatty acid exposure covaried positively with these three HRV indices only among participants expending 2000 kcal per week or more in physical activity. These latter findings were noted for DHA but not EPA.
CONCLUSIONS: These results suggest that the cardiovascular benefits of n-3 fatty acid consumption may be mediated, in part, by effects on cardiac autonomic control and may be dependent upon concomitant habitual exercise.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Exercise; HRV; n-3 fatty acids

Mesh:

Substances:

Year:  2012        PMID: 22704872      PMCID: PMC3484192          DOI: 10.1016/j.ijcard.2012.05.110

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  42 in total

1.  Association between n-3 fatty acid status in blood and electrocardiographic predictors of arrhythmia risk in healthy volunteers.

Authors:  Ingeborg A Brouwer; Peter L Zock; Ludovic G P M van Amelsvoort; Martijn B Katan; Evert G Schouten
Journal:  Am J Cardiol       Date:  2002-03-01       Impact factor: 2.778

2.  A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression.

Authors:  Pao-Yen Lin; Shih-Yi Huang; Kuan-Pin Su
Journal:  Biol Psychiatry       Date:  2010-05-10       Impact factor: 13.382

3.  Do the high-frequency indexes of HRV provide a faithful assessment of cardiac vagal tone? A critical theoretical evaluation.

Authors:  Erez Pyetan; Solange Akselrod
Journal:  IEEE Trans Biomed Eng       Date:  2003-06       Impact factor: 4.538

Review 4.  Physical activity and cardiovascular health: lessons learned from epidemiological studies across age, gender, and race/ethnicity.

Authors:  Eric J Shiroma; I-Min Lee
Journal:  Circulation       Date:  2010-08-17       Impact factor: 29.690

Review 5.  Improvements in heart rate variability with exercise therapy.

Authors:  Faye S Routledge; Tavis S Campbell; Judith A McFetridge-Durdle; Simon L Bacon
Journal:  Can J Cardiol       Date:  2010 Jun-Jul       Impact factor: 5.223

6.  Long-chain omega-3 fatty acids and blood pressure.

Authors:  James C Liu; Sarah M Conklin; Stephen B Manuck; Jeffrey K Yao; Matthew F Muldoon
Journal:  Am J Hypertens       Date:  2011-07-14       Impact factor: 2.689

7.  Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease.

Authors:  Barbara Villa; Laura Calabresi; Giulia Chiesa; Patrizia Risè; Claudio Galli; Cesare R Sirtori
Journal:  Pharmacol Res       Date:  2002-06       Impact factor: 7.658

8.  Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study.

Authors:  J Dyerberg; D C Eskesen; P W Andersen; A Astrup; B Buemann; J H Christensen; P Clausen; B F Rasmussen; E B Schmidt; T Tholstrup; E Toft; S Toubro; S Stender
Journal:  Eur J Clin Nutr       Date:  2004-07       Impact factor: 4.016

9.  Fish oil reduces heart rate and oxygen consumption during exercise.

Authors:  Gregory E Peoples; Peter L McLennan; Peter R C Howe; Herbert Groeller
Journal:  J Cardiovasc Pharmacol       Date:  2008-12       Impact factor: 3.105

Review 10.  Cardiac autonomic neural remodeling and susceptibility to sudden cardiac death: effect of endurance exercise training.

Authors:  George E Billman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-14       Impact factor: 4.733

View more
  3 in total

1.  Concurrent physical activity modifies the association between n3 long-chain fatty acids and cardiometabolic risk in midlife adults.

Authors:  Matthew F Muldoon; Kirk I Erickson; Bret H Goodpaster; John M Jakicic; Sarah M Conklin; Akira Sekikawa; Jeffrey K Yao; Stephen B Manuck
Journal:  J Nutr       Date:  2013-07-24       Impact factor: 4.798

2.  Clinical implications of eicosapentaenoic acid/arachidonic acid ratio (EPA/AA) in adult patients with congenital heart disease.

Authors:  Miki Kanoh; Kei Inai; Tokuko Shinohara; Hirofumi Tomimatsu; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2017-07-05       Impact factor: 2.037

3.  Multimodal Preventive Trial for Alzheimer's Disease: MIND-ADmini Pilot Trial Study Design and Progress.

Authors:  S Sindi; C Thunborg; A Rosenberg; P Andersen; S Andrieu; L M Broersen; N Coley; C Couderc; C Z Duval; G Faxen-Irving; G Hagman; M Hallikainen; K Håkansson; J Lehtisalo; N Levak; F Mangialasche; J Pantel; E Kekkonen; A Rydström; A Stigsdotter-Neely; A Wimo; T Ngandu; H Soininen; T Hartmann; A Solomon; M Kivipelto
Journal:  J Prev Alzheimers Dis       Date:  2022
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.